When China’s health leadership announced they have found the anti-influenza drug Avigan (Favipiravir) effective in treating COVID-19 disease in adult patients, Japan was expected to follow. China’s positive reception of Avigan (Favipiravir) contrasts with Japan’s continued reservations. Avigan initially obtained regulatory approval in Japan during 2014. Since then, clinical studies have indicated Avigan (Favipiravir) may cause serious side effects. However, on March 17, 2020, Zhang Xinmin, China’s director of the National Center for Biotechnology Development said ‘Avigan (Favipiravir) was found to be effective in clinical trials during 2020.’ These studies in China concluded this medicine was effective in treating coronavirus-related symptoms and had no obvious side effects.
MEDICINE & SCIENCE
HEALTH & MEDICINEMEDICINE & SCIENCE
MoA—The sudden appearance of a new type of coronavirus against which no one had any immunity led to a sudden rise of cases with severe respiratory difficulties. These require up to three weeks of ventilator support and intensive care. Our healthcare systems are not capable of working under such an onslaught. If they get overwhelmed other cases which require intensive care will fall by the wayside. The number of unnecessary deaths will then start to explode. The only possible way to avoid such an outcome is to minimize contacts between humans to stop the mass infection wave.
AMERICAN BRAINWASHAMERICAN EXCEPTIONALISMMEDIA SCOUNDRELSMEDICINE & SCIENCE
TOMAS PUEYO—Our healthcare system is already collapsing.
Countries have two options: either they fight it hard now, or they will suffer a massive epidemic.
If they choose the epidemic, hundreds of thousands will die. In some countries, millions.
And that might not even eliminate further waves of infections.
If we fight hard now, we will curb the deaths.
We will relieve our healthcare system.
We will prepare better.
We will learn.
The world has never learned as fast about anything, ever.
And we need it, because we know so little about this virus.
All of this will achieve something critical: Buy Us Time.
AMERICAN BRAINWASHAMERICAN EXCEPTIONALISMAMERICAN PARTY DUOPOLYMED FRONTMEDICINE & SCIENCE
DR CARL JUNEAU—It’s here. COVID-19 hit China, Europe, and is grinding America to a halt. On March 13, President Trump declared a national emergency. Still, as a PhD in Public Health who specialised in epidemiology, I’m worried. Here’s why:
•The virus is spreading quickly
•It’s 10-40 times more deadly than regular flu (3.7% of people infected worldwide have died)
•16% of people infected get “seriously ill” (Guan et al. 2020)
•In Italy, hospitals are overwhelmed (an intensivist said “patients above 65 are not even assessed”—they’re forced to let them die).
•US Centers for Disease Control projected “200,000 to 1.7 million people dying” and 2.4 to 21 million requiring hospitalization—but the country only has 924,107 staffed beds
•Based on 5 other countries, it looks like the virus will be around for 3-4 months
AMERICAN BRAINWASHAMERICAN EXCEPTIONALISMAMERICAN STUDIESAMERICAN WAY OF LIFEHEALTH & MEDICINEMEDICINE & SCIENCE
DAVE LINDORFF-There is an element of panic, since it’s becoming clear that this once-in-a-lifetime pandemic is looking potentially much worse than people up until now had been led to believe. In this so-called “epicenter,” for example, the number of “presumptive” cases of COVID-19 infection is currently 17 (since testing kits are scarce in the US, only six of the PA cases have been tested and they were all positive). That’s just about half the state’s total of 33 as of today. One MontCo resident has died so far, in a hospital in Philadelphia.